Abstract
Objective To examine if atrial fibrillation at the time of emergency transport to tertiary care hospital by air ambulance is associated with increased mortality risk.
Design Retrospective cohort study. Logistic regression and Cox regression were used to assess associations of condition with outcome (mortality). Propensity score matching (1:1) was used to identify the comparison cases.
Setting One tertiary care centre in sparsely populated northern Sweden
Participants Critical care cases undergoing emergent fixed-wing air transport in the northern healthcare region of Sweden was included. 2143 cases were included in the study between 2000-2016.
Primary and secondary outcomes measures The primary outcome was mortality risk at 90-days post transport in cases with atrial fibrillation during the fixed-wing air ambulance transport. The secondary outcome measures were vasopressor and impaired oxygenation was associated with mortality at 90-days post transport.
Results Atrial fibrillation showed a higher 90-day post transport mortality risk estimate in the multivariate analysis of all cases, hazard ratio (HR) 1.70 (95% CI 1.08-2.67, p=0.022). In a propensity matched analysis, no increased mortality risk for atrial fibrillation was observed at the same time interval with hazard ratio 1.22 (0.65-2.27, p=0.536). In the secondary analysis, vasopressor use was associated with atrial fibrillation at the time of transport whereas impaired oxygenation was not associated with an increased risk of atrial fibrillation.
Conclusion No increased mortality risk at 90 days was seen for cases with atrial fibrillation at time of transport in this cohort using a propensity score matched approach.
Strengths and limitations
Explores the scarcely studied topic of mortality risk and atrial fibrillation at time of transport with fixed-wing air ambulance
Quasi-experimental approach with propensity score matching to handle selection bias
No co-morbidity and disease severity data which risk confounding results
A single transport system was studied which limits generalizability
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by intramural funding from the County Healthcare Authority in Vasterbotten for the study into Air Ambulance Intensive Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical permission was granted by the Swedish Ethical Review Authority (Dnr 2019-06525).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
hannah.bassek{at}gmail.com
helena.nystrom{at}umu.se
roman.aroch{at}umu.se
michael.haney{at}umu.se
Data availability
Data from which the study is derived are available upon reasonable request from the corresponding author. Data is not made immediately accessible because of Swedish privacy laws.
